Keratoconus progression is not inhibited by reducing eyelid muscular force with botulinum toxin A treatment: a randomized trial

Related authors

• Adimara da Candelaria Renesto
• Teissy Hentona Osaki
• Midori Hentona Osaki
• Flávio E. Hirai
• Mauro Campos

Related articles

• Corneal crosslinking efficacy in patients with keratoconus under 18 years of age
• Evaluation of perioperative pachymetry of thin corneas during corneal crosslinking using hypo-osmolar riboflavin and hydroxypropyl methylcellulose
• Accelerated corneal cross-linking with hypo-osmolar riboflavin in thin keratoconic corneas: 2-year follow-up
• Intrastromal autologous blood injection for treating corneal hydrops
• Corneal crosslinking via the Dresden protocol versus the accelerated approach in pediatric patients - a retrospective comparative study
• Evaluation of unilateral corneal collagen cross-linking on fellow untreated eyes of patients with keratoconus
• Deep anterior lamellar keratoplasty versus penetrating keratoplasty: comparison of clinical outcomes in contralateral eyes
• Botulinum toxin A for the treatment of strabismus in children with neurological impairment
• Anterior lamellar corneoscleral keratoplasty for the management of corneal thinning following treatment with mitomycin-C and interferon to treat highly suspected ocular surface squamous neoplasia: a case report
• Corneal warpage in contact lens wearer with keratoconus: a case report

Click here to search